Topiramate Capsule, Extended Release
Product Images NDC 10370-367

The text provides a table displaying cumulative rates for Time to First Seizure of two groups of participants taking Topramate at different dosages (50 mg/day and 400 mg/day) over time in days represented on the horizontal axis. The data is charted on a vertical axis displaying percentages ranging from 0 to 300.*

This text describes the change in the average monthly migraine period rate during the double-blind phase of a study comparing the effectiveness of different doses of topiramate and placebo. The results are presented in tabular form, showing the number of subjects and the average monthly migraine period rate (+SE) for each treatment group. The text also includes statistical significance values for the differences between the treatment groups.*

This is a description of a drug called Topiramate, which is enclosed in extended-release capsules of 25 mg. It contains information about proper usage, dosage and prescribing, storage requirements, and contact information for the manufacturer and distributor. This text advises the pharmacist to dispense the medication guide to each patient separately. No non-English characters were detected.*

This is a description of a medication for which the brand name is not available, but it contains topiramate 50 mg. The medication comes in a container with 30 extended-release capsules, each with a flesh opaque cap and body. It is important that the patient swallows the capsule whole and intact, without opening, crushing, chewing, or sprinkling its contents on the food. More information about dosage and other prescribing details can be found in the package outsert. The medication should be stored at room temperature and protected from moisture and light. It is manufactured and distributed by Par Pharmaceutical in the US, and it was made in India. A manufacturing license number is also provided.*

This is a prescription medication with the brand name "YPAR" and the generic name "Topiramate". It comes in the form of extended-release capsules of 100mg strength, with each bottle containing 30 capsules. Patients are advised to swallow the capsule whole and not open, crush, chew, or sprinkle the contents on food. The medication guide provided separately should be dispensed by the pharmacist to each patient. The recommended dosage and other prescribing information can be found in the package insert. The medication should be stored in a tight, light-resistant container, away from moisture and light, at a controlled room temperature of 20°C to 25°C. The drug is manufactured in India by Par Formulations Private Limited and distributed by Par Pharmaceuticals, Chestnut Ridge, NY, USA.*